Results 91 to 100 of about 13,974 (221)

Pharmacology and therapeutics of bronchodilators [PDF]

, 2012
Bronchodilators are central in the treatment of of airways disorders. They are the mainstay of the current management of chronic obstructive pulmonary disease (COPD) and are critical in the symptomatic management of asthma, although controversies around ...
Matera MG, Cazzola M, Calzetta, L, Clive P. Page, Calzetta L, Calzetta, Luigino, Cazzola, M, Luigino Calzetta, Page CP, Page, Clive P., Page, CP, CAZZOLA, MARIO, Mario Cazzola, Matera, M. Gabriella, Matera, MG, MATERA, Maria Gabriella, M. Gabriella Matera   +16 more
core   +1 more source

Cost comparison of two aerosol bronchodilator delivery methods in patients with acute asthma in the emergency department : intermittent nebulization versus metered-dose inhaler with valved spacer [PDF]

, 2002
Objetivo: A administração de broncodilatadores através de dispositivo com aerossol dosimetrado (spray) ou através de nebulizador é equivalente em eficácia no tratamento da asma aguda. Alguns estudos sugerem que o spray tem um custo menor.
Hoffmann, Cristine Feliciati, Fernandes, Andreia Kist, Mallmann, Felipe, Krost, Daniel Papich, Franciscatto, Eduardo, Innocenti, Cassiano, Dalcin, Paulo de Tarso Roth, Kang, Suzie Hyeona, Piovesan, Deise Marcela   +8 more
core  

Current and potential improvements in the treatment of asthma from increased understanding of airway pathophysiology

Allergology International, 2002
The mainstay of chronic asthma management consists of using pharmacological agents that induce bronchodilatation, such as short-acting β-adrenergic receptor agonists (bronchodilators or relievers), and that control the chronic inflammatory process, such ...
Kian Fan Chung
doaj   +1 more source

Tiotropium for Asthma - Promise and Caution [PDF]

, 2012
Anticholinergic agents have been available for the treatment of airways obstruction for many decades. For patients with chronic obstructive pulmonary disease (COPD), many practitioners believe that these drugs have become the bronchodilator of choice ...
Bel, Elisabeth H.
core   +1 more source

Evaluating bronchodilator response in pediatric patients with post-infectious bronchiolitis obliterans: use of different criteria for identifying airway reversibility

Jornal Brasileiro de Pneumologia
Objective: Post-infectious bronchiolitis obliterans (PIBO) is a clinical entity that has been classified as constrictive, fixed obstruction of the lumen by fibrotic tissue.
Rita Mattiello, Paula Cristina Vidal, Edgar Enrique Sarria, Paulo Márcio Pitrez, Renato Tetelbom Stein, Helena Teresinha Mocelin, Gilberto Bueno Fischer, Marcus Herbert Jones, Leonardo Araújo Pinto   +8 more
doaj   +1 more source

Are there specific clinical characteristics associated with physician’s treatment choices in COPD?

Respiratory Research, 2019
Background The number of pharmacological agents and guidelines available for COPD has increased markedly but guidelines remain poorly followed. Understanding underlying clinical reasoning is challenging and could be informed by clinical characteristics ...
Nicolas Roche, Anestis Antoniadis, David Hess, Pei Zhi Li, Eric Kelkel, Sylvie Leroy, Christophe Pison, Pierre-Régis Burgel, Bernard Aguilaniu, COLIBRI COPD Research Group   +9 more
doaj   +1 more source

Medications in Bronchospasm and Asthma among the Critically Ill Patients: A Drug Utilization Study from Southern India [PDF]

, 1970
Objective: Critically ill patients are prone for altered reactivity of the airway and drug therapy has pivotal role in the management of bronchospasm. The objective of the study was to evaluate the prescribing patterns and adverse effects of therapeutic ...
Jenny John, Lisha Jenny John, Mohamed Arifulla, Padmini Devi, Shoba Guido   +4 more
core   +1 more source

Inhalation therapy. Oxygen administration, humidification, and aerosol therapy [PDF]

In addition to receiving treatment for the primary disease, patients with advanced respiratory disorders may benefit from other forms of respiratory support.

core   +1 more source

Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study

International Journal of COPD, 2017
Jadwiga A Wedzicha,1 Nanshan Zhong,2 Masakazu Ichinose,3 Michael Humphries,4 Robert Fogel,5 Chau Thach,5 Francesco Patalano,6 Donald Banerji5 1National Heart and Lung Institute, Imperial College London, London, UK; 2State Key Laboratory of Respiratory ...
Wedzicha JA, Zhong N, Ichinose M, Humphries M, Fogel R, Thach C, Patalano F, Banerji D   +7 more
doaj  

A systematic review of the effects of bronchodilators on exercise capacity in patients with COPD [PDF]

, 2002
One of the major goals of bronchodilator therapy in patients with COPD is to decrease airflow limitation in the airways and, as a consequence, improve dyspnea and exercise tolerance.
Postma, DS, Ten Hacken, NHT, Koeter, GH, Wijkstra, PJ, Kerstjens, HAM; id_orcid, Liesker, JJW   +5 more
core   +2 more sources